Blog Category
Tag: DNAi
Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type.
Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide!
Download the Guide
2023 MVCA Research Report
Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the ReportUpcoming Events
- Mar 5 MVCA Member Only Networking Event
- Jun 10 MVCA Member Only Networking Event
- Oct 9 MVCA 18th Annual Awards Celebration
Learn More
November 10
ProNAi Expands Management Team and Presents Encouraging Phase I Study Results for Lead Cancer Drug at Cancer Meeting
Read More
ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.
Read More